Patent ID: 8706526

Claim:
In a computer processor, a method of generating a neuropsychiatric report presenting patient-specific information relevant to the treatment of a patient's neuropsychiatric disorder, the method comprising: collecting, by the processor, results of biomarker tests specific to the patient for at least one biomarker for each of: (1) the patient's limbic mediated autonomic arousal system, wherein the biomarker is related to a gene consisting of solute carrier family 6 member 4 (SLC6A4); (2) the patient's prefrontal-subcortical mediated emotional valence, attention, reward and executive brain systems, the biomarker related to a gene selected from the group consisting of: catechol-O-methyltransferase (COMT), and dopamine receptor D2 (DRD2); and (3) the patient's synaptic mediated long-term potentiation and long-term depression (LTP-LTD) system the biomarker related to a gene selected from the group consisting of: calcium channel, voltage-dependent, L type, alpha 1C subunit (CACNA1C), and ankyrn 3 (ANK3); selecting, by the processor, an interpretive comment based on the results of the biomarker tests; organizing, by the processor, the results of the biomarker tests and one or more interpretive comments in a patient-specific neuropsychiatric report; and presenting the patient-specific neuropsychiatric report, wherein the report comprises an interpretive analysis of the neuropsychological significance of the result of any biomarker test collected, the report further comprising the one or more interpretive comments, the interpretive comments including a description of an association with a disorder or a dysfunction of brain activity or a disorder and dysfunction of brain activity based on the biomarker test results.